Global Transfection Reagents and Equipment Market is valued at approximately USD 1031.6 million in 2021 and is anticipated to grow with a healthy growth rate of more than 8.12% over the forecast period 2022-2028. Transfection is referred to as a process of artificially introducing nucleic acids (like RNA or DNA) into the cells by the usage of reagents and equipment. These reagents and equipment are connected with nucleic acids and target cell membrane for the study of gene mutation, protein function, and gene function & expression. Factors such as the rising prevalence of cancer worldwide, growing R&D investment by the pharmaceutical and biotechnology industry, and a surge in demand for synthetic genes are creating a lucrative market demand across the globe. According to Statista, in 2020, the total overall R&D expenditure in the pharmaceutical sector accounted for USD 198 billion and it is projected to reach around USD 248 billion by the year 2025. However, several concerns associated to reduce cytotoxicity and immunogenicity impede the growth of the market over the forecast period of 2022-2028. Also, the increasing development of nanotechnology & drug delivery systems and growing advancements in transfection technologies are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Transfection Reagents and Equipment Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share of USD 338.8 million owing to the growing investment in technological advancements in transfections and rising R&D activities by pharmaceutical and biotechnology companies. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR of 9.36% over the forecast period 2022-2028. Factors such as the rising cases of chronic disorders, and the rising emphasis on the introduction of DNA plasmids, would create lucrative growth prospects for the Transfection Reagents and Equipment Market across the Asia-Pacific region.

Major market players included in this report are:

MaxCyte Inc.

Thermo Fisher Scientific, Inc.

Promega Corporation

Hoffmann-La Roche Ltd.

QIAGEN N.V.

Polyplus-transfection SA

Bio-Rad Laboratories

Lonza Group

Sigma-Aldrich Corporation

Mirus Bio LLC

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Reagents

Instruments

By Application:

Biomedical Research

Gene Expression Studies

Cancer Research

Transgenic Model

Protein Production

Therapeutic Delivery

By End-Use:

Academic & Research Institutes

Pharmaceutical & Biotechnology Companies

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Transfection Reagents and Equipment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors